Cable Hill Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cable Hill Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-148	Closed	-$4K	–	823
2019 Q1	$4K	Hold	148	–	–	﹤0.01%	686
2018 Q4	$3K	Hold	148	–	–	﹤0.01%	692
2018 Q3	$3K	Sell	148 -26	-15%	-$494	﹤0.01%	691
2018 Q2	$3K	Buy	+174	New	+$2.65K	﹤0.01%	807
2016 Q4	–	Sell	-267	Closed	-$5K	–	966
2016 Q3	$5K	Buy	+267	New	+$5.22K	﹤0.01%	590

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cable Hill Partners's HZNP Position: Q2 2019 in Review

Cable Hill Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019, closing a stake of 148 shares — an estimated $4K sold.

Cable Hill Partners first reported a position in HZNP in Q3 2016 and held it in 5 quarters. The position peaked at $5K in Q3 2016. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

Cable Hill Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Cable Hill Partners sold 148 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2019, an estimated $4K.
Cable Hill Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016 and held it in 5 quarters.
Cable Hill Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5K in Q3 2016.
272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.